TrialJAMA oncology2019
Efficacy and Long-term Peripheral Sensory Neuropathy of 3 vs 6 Months of Oxaliplatin-Based Adjuvant Chemotherapy for Colon Cancer: The ACHIEVE Phase 3 Randomized Clinical Trial.
Takayuki Yoshino et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
67 papers cite itlatest 60 shown
this paperpooled ittrialcites it